Flubromazepam

Flubromazepam

Flubromazepam
Systematic (IUPAC) name
7-Bromo-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one
Clinical data
Legal status
  • US: Not FDA approved; Unscheduled
Routes of
administration
Oral
Identifiers
CAS Registry Number  YesY
PubChem CID:
ChemSpider
Chemical data
Formula C15H10BrFN2O
Molecular mass 333.16 g/mol

Flubromazepam is the name used for a benzodiazepine derivative which was first made in 1960,[1] but was never marketed and did not receive any further attention or study until late 2012. It is a structural analog of phenazepam in which the chlorine atom has been replaced by a fluorine atom.

Flubromazepam is currently being studied.[2]

A closely related compound, 5-(2-bromophenyl)-7-fluoro-1,3-dihydro-2H-1,4-benzodiazepin-2-one (below), also appears to have been sold under the same name.

Alternate isomer

See also

References

  1. ^ US 3136815, "Amino substituted benzophenone oximes and derivatives thereof" 
  2. ^ Moosmann B, et al. Characterization of the designer benzodiazepines pyrazolam and flubromazepam and study on their detectability in human serum and urine samples. Institute of Forensic Medicine, Forensic Toxicology, University Medical Center Freiburg, Freiburg, Germany